Background {#Sec1}
==========

Worldwide in 2018, about 19 million women aged 15 years or older were living with HIV \[[@CR1]\] and an estimated five hundred children per day were newly infected with HIV, mainly due to mother-to-child transmission \[[@CR1]\]. In Sub-Saharan countries including Kenya, Ethiopia, Uganda and the United Republic of Tanzania, an estimated 38% of new HIV infections among children were attributed to pregnant and breastfeeding women not being retained on antiretroviral therapy (ART) in 2018 \[[@CR2]\]. In addition, research shows that by increasing the access and sustained adherence to ART, maternal health outcomes \[[@CR3]\] and life expectancy of women living with HIV can be improved \[[@CR3], [@CR4]\].

In Kenya, an estimated 910,000 women aged 15 years or older were living with HIV as of 2018 \[[@CR1]\], with data indicating that HIV was transmitted from mother-to-child in 12% of HIV exposed children in 2018 \[[@CR2]\]. Since mother-to-child transmission is still unacceptably high, it is important to identify factors that can improve ART adherence among pregnant women and outcomes of prevention of mother-to-child transmission of HIV (PMTCT) care. One such factor is HIV status disclosure, which has been linked to increased ART adherence \[[@CR5], [@CR6]\] as well as facility delivery \[[@CR5], [@CR7]\], early infant HIV testing \[[@CR8]\], infant antiretroviral prophylaxis \[[@CR9], [@CR10]\], and adherence to infant feeding guidelines \[[@CR11]\].

PMTCT care as well as ART to prevent sexual transmission, condom use, and voluntary male medical circumcision are successful strategies for HIV prevention in low and middle-income countries \[[@CR2], [@CR3], [@CR12]\]. However, qualitative evidence from sub-Saharan Africa (SSA) and Asia has shown that concerns about unintentional HIV status disclosure and HIV related stigma are barriers to participate in PMTCT care among pregnant women \[[@CR13]--[@CR18]\]. Qualitative studies have also identified other important barriers to HIV status disclosure including concerns about separation or divorce \[[@CR19]--[@CR23]\], conflicts with a partner \[[@CR19], [@CR21]\], intimate partner violence (IPV) \[[@CR19]--[@CR21], [@CR23]\] and stigma in the family or community \[[@CR20], [@CR23]\]. However, only a few quantitative studies have been conducted to further identify social concerns related to HIV disclosure and participation in PMTCT care. A recent cross-sectional study conducted in Uganda found that concerns about abandonment, being beaten, and loss of financial support were the most prevalent reasons for non-disclosure to a partner \[[@CR24]\]. Other studies from Zimbabwe, South Africa, and Barbados have estimated that women were less likely to disclose their HIV status if they were concerned about being divorced \[[@CR25]\], subjected stigma \[[@CR26]\] and abnormal reactions \[[@CR27]\].

It is important to increase the understanding among healthcare workers and policymakers of pregnant women's social and emotional barriers to HIV disclosure and participation in PMTCT care. This knowledge could be used to improve counselling in PMTCT care, improve women's health and reduce mother-to-child transmission of HIV. The aim of this study is therefore to investigate how social concerns related to participation in PMTCT care are associated with HIV status disclosure to partners and relatives among pregnant women living with HIV in western Kenya.

Methods {#Sec2}
=======

Study design, population, and location {#Sec3}
--------------------------------------

This is a cross-sectional study of pregnant women living with HIV and enrolled in the WelTel PMTCT trial from June 2015 to July 2016. The WelTel PMTCT trial is a multicentre randomised controlled trial designed to test the efficacy of weekly interactive mobile text messages for improving retention in PMTCT care among women and infants in western Kenya \[[@CR28]\]. Pregnant women living with HIV, 18 years or older, consecutively presenting for their first antenatal care (ANC) visit in their current pregnancy were informed about the WelTel PMTCT trial by a trained local research assistant at their clinic. In order to be included, women had to own or have access to a mobile phone, be able to send text messages or have someone in close contact who could respond to text messages, and plan to be a resident of the clinic catchment area up to 24 months post-delivery. Established HIV infection was defined as two repeated Determine or Colloidal Gold tests for women newly diagnosed, or referral from HIV comprehensive care clinic for those with known HIV infection. Out of 735 women screened for trial participation, 600 women were enrolled in the WelTel PMTCT trial (Fig. [1](#Fig1){ref-type="fig"}) at six ANC clinics. Fig. 1Flow chart of screening, enrolment, reasons for non-participation and selection of participants. PMTCT, Prevention of mother-to-child transmission of HIV

For our study, we used data from four out of the six ANC clinics in WelTel PMTCT, including a total of 515 women. At these four ANC clinics, located in Usain Gishu and Trans Nzoia counties, an enrolment survey collected information on social concerns related to participation in PMTCT care, in addition to other questions of HIV status disclosure, HIV testing, date and year of HIV diagnosis, barriers for accessing healthcare as well as mobile phone access and use that were asked at all six sites. Data were collected in interviews with trained fieldworkers using a structured questionnaire developed for this study (Additional file [1](#MOESM1){ref-type="media"}). Women diagnosed with HIV on the day of enrolment had no opportunity of having disclosed their HIV status and were therefore excluded from this analysis, leaving a study population of 437.

At the time of the enrolment, all clinics had adopted the World Health Organization's (WHO's) PMTCT Option B+ guidelines (i.e., life-long ART offered to all pregnant women living with HIV) \[[@CR29]\]. All participants were informed that participation in the study was voluntary and that non-participation or withdrawal of consent would not affect the care. Women were interviewed face-to-face in a private space at the local ANC clinic to ensure participants' comfort and confidentiality. All women provided informed consent, and the trial was approved by the Institutional Research and Ethics Committee at Moi University, Kenya (FAN: IREC 1292), and the Regional Ethics Committee, Stockholm, Sweden (2018/742--31/1).

Measures {#Sec4}
--------

### Sociodemographic characteristics {#Sec5}

Women were interviewed about several lifestyle and social factors such as age at enrolment, educational status, marital status, cohabitation status, working status, and economic responsibility to other people. A current relationship was defined as being married or cohabitating with a husband/partner. Educational status was categorized as primary schooling or less, secondary schooling, or higher than secondary education. Working status was categorized as working outside the household (i.e., employed, self-employed, casual labour, farm work) or not working outside the household (i.e., unemployed, homemaker, student).

### Disclosure of HIV status {#Sec6}

The participants were asked if they had disclosed their HIV status and, if so, to whom: a partner (i.e., spouse or steady sexual partner); a relative (i.e., mother, father, sister, brother, child, or another relative); or another person.

### Social concerns related to participation in PMTCT care {#Sec7}

Questions about social concerns related to participation in PMTCT care were developed based on previous qualitative research of issues related to HIV status disclosure, uptake and retention in PMTCT care in Kenya \[[@CR30]--[@CR32]\]. The questionnaire was also developed in consultation with experienced local PMTCT providers in western Kenya. A pilot study was conducted prior to the study to test the feasibility of the questionnaire among pregnant women enrolled in PMTCT care in western Kenya. The participants were asked if they were ever concerned that attending HIV care or taking ART would lead to involuntary disclosure of HIV status (yes/uncertain/no). They were also asked if they were concerned that attending PMTCT visits or taking ART would lead to them being a burden or source of concern for others (yes/no); them losing the respect of family or community (yes/no); them being isolated or lacking support from family or friends (yes/no); them being teased or insulted (yes/no); them being separated from a partner (defined as separation, divorce or abandonment from spouse or partner, yes/no); them having a conflict with a partner (yes/no); them losing customers or losing a job (yes/no); them being a victim of IPV (defined as beating or other forms of physical violence by spouse or partner, yes/no); them having a child taken away (yes/no); or property taken away (yes/no).

Statistical analysis {#Sec8}
--------------------

The associations between social concerns and HIV status disclosure to a partner or a relative were assessed by calculating odds ratios (OR) and 95% confidence intervals (CI) using multivariable-adjusted logistic regression. Based on previous literature of factors associated with HIV status disclosure, ORs were adjusted for age \[[@CR33], [@CR34]\], educational level \[[@CR35]\], marital- and cohabitation status \[[@CR26], [@CR36]--[@CR38]\], working status \[[@CR39]\], time since HIV diagnosis \[[@CR33]\], living with relatives \[[@CR40]\] and economic situation \[[@CR19], [@CR26], [@CR33]\]. A variable was excluded from the logistic regression model if a response alternative was reported by \< 10 subjects (excluding concerns about IPV, a child taken away and property taken away). Fourteen women chose not to respond to the question about concern of involuntary HIV status disclosure, and those subjects were excluded when calculating the prevalence of that specific concern. They were also excluded from the logistic regression analysis. We further investigated whether ANC clinic of enrolment attenuated the observed findings by calculating both unadjusted and adjusted OR and 95% CI including ANC clinic of enrolment. All statistical analyses were performed using SPSS (IBM Corp. Released in 2016. IBM SPSS Statistics for Windows, Version 24.0. Armonk, NY: IBM Corp).

Results {#Sec9}
=======

The characteristics of the 437 pregnant women are presented in Table [1](#Tab1){ref-type="table"}. Women enrolled were 18--44 years old and the mean age was 29.9 years (SD = 5.7 years). As can be seen in Table [1](#Tab1){ref-type="table"}, the majority reported that they were in a current relationship. Women who were not in a relationship were single (13.7%), divorced or separated (3.2%), or widowed (1.8%). The mean time since HIV diagnosis was 53.2 months (SD = 47.5). Table 1Characteristics of pregnant women admitted to PMTCT at first antenatal care visit (*N* = 437)CharacteristicN (%)**Age (years)** 18--2484 (19.2) 25--29122 (27.9) 30--34123 (28.1) 35--44108 (24.7)**Highest education**  ≤ Primary schooling195 (44.6) Secondary schooling166 (38.0) Higher education76 (17.4)**In a current relationship**^**a**^355 (81.2)**Living with relatives**97 (22.2)**Working outside the household**179 (41.0)**Economic responsibility** Only for herself247 (56.5) For more people than herself190 (43.5)**Time since HIV diagnosis**  \< 6 months89 (20.4)  ≥ 6 months348 (79.6)*PMTCT* Prevention of mother-to-child transmission of HIV^a^ In a current relationship i.e. married or cohabitating with a husband/partner

Disclosure of HIV status {#Sec10}
------------------------

HIV status disclosure to a relative was reported by 202 (46.2%) and to another person by 34 (7.8%). Among the 355 women in a current relationship, 284 (80.0%) had disclosed to a partner. Figure [2](#Fig2){ref-type="fig"} shows the prevalence of HIV status disclosure in relation to womens' age. Fig. 2Prevalence of HIV status disclosure and age at enrolment in PMTCT care (*N* = 437), PMTCT, Prevention of mother-to-child transmission of HIV.

Social concerns among pregnant women at enrolment in PMTCT care {#Sec11}
---------------------------------------------------------------

Pregnant womens' social concerns at enrolment in PMTCT care are presented in Fig. [3](#Fig3){ref-type="fig"}. As can be seen in Fig. [3](#Fig3){ref-type="fig"}, the most prevalent social concern, was that of involuntary HIV status disclosure. This was followed by the concern of being a burden or source of concern for others, losing respect of family or community, isolation or lack of support from family or friends, teasing or insulting, separation from partner, conflict with partner, losing customers or a job, intimate partner violence, having a child taken away, and property taken away. Fig. 3Prevalence of social concerns among pregnant women at enrolment in PMTCT care (*N* = 437). PMTCT, Prevention of mother-to-child transmission of HIV. Fourteen participants chose to not respond to the question about concern of involuntary HIV status disclosure, and they were excluded when the prevalence of that specific concern was calculated

Social concerns and HIV status disclosure to partner {#Sec12}
----------------------------------------------------

Table [2](#Tab2){ref-type="table"} shows the association of social concerns and HIV disclosure to a partner and a relative. As shown in Table [2](#Tab2){ref-type="table"}, concerns that participation in PMTCT care would lead to separation from a partner, conflict with a partner, or isolation or lack of support from family or friends were all associated with significantly lower odds of having disclosed HIV status to a partner. Women aged 25--29 years (OR 0.30; 95% CI: 0.11--0.81), 30--34 years (OR 0.30; 95% CI: 0.11--0.86) and 35--44 years (OR 0.15; 95% CI: 0.05--0.44) had significantly lower odds of having disclosed to a partner as compared to women aged 18--24 years. In addition, women diagnosed with HIV \< 6 months before enrolment compared with HIV diagnosis ≥6 months (OR 0.19; 95% CI: 0.09--0.39) had statistically significantly lower odds of having disclosed to a partner. Table 2Social concerns and association with HIV status disclosure (*N* = 423)Disclosure of HIV status to:%Partner^a^\
OR (95% CI)Relative^b^\
OR (95% CI)Concern that attending PMTCT visits or takingART would lead to:Involuntary HIV status disclosure^c^ Yes21.50.75 (0.39--1.44)1.02 (0.60--1.71) Uncertain3.80.62 (0.14--2.70)1.69 (0.53--5.41) No74.71.00 (ref.)1.00 (ref.)Being a burden or source of concern for others Yes16.10.87 (0.38--1.98)1.17 (0.63--2.16) No83.91.00 (ref.)1.00 (ref.)Losing respect of family or community Yes11.30.95 (0.34--2.63)0.62 (0.29--1.30) No88.71.00 (ref.)1.00 (ref.)Isolation or lack of support from family or friends Yes9.50.33 (0.12--0.85)0.37 (0.16--0.85) No90.51.00 (ref.)1.00 (ref.)Teasing or insulting Yes8.02.09 (0.62--7.06)0.93 (0.42--2.09) No92.01.00 (ref.)1.00 (ref.)Separation^d^ from partner Yes5.40.17 (0.05--0.57)0.44 (0.15--1.31) No94.61.00 (ref.)1.00 (ref.)Conflict with partner Yes5.00.18 (0.05--0.67)1.73 (0.58--5.15) No95.01.00 (ref.)1.00 (ref.)Losing customers or a job Yes4.70.42 (0.11--1.66)1.00 (0.36--2.76) No95.31.00 (ref.)1.00 (ref.)*PMTCT* Prevention of mother-to-child transmission of HIV, *ART* Antiretroviral therapy, *OR* Odds ratio, *CI* Confidence interval^a^ Partner i.e. spouse or steady sexual partner^b^ Relative i.e. mother, father, brother, sister, child or other relative^c^ This question was asked more broadly to include general HIV care^d^ Separation i.e. separation, divorce or abandonmentMultivariable logistic regression model adjusted for age, education, marital-and cohabitation status, employment status, economic responsibility to other people, living with relatives, and time since HIV diagnosis

Social concerns and HIV status disclosure to relative {#Sec13}
-----------------------------------------------------

Concern that participation in PMTCT care would lead to isolation or lack of support from family or friends was associated with significantly lower odds of having disclosed to a relative (Table [2](#Tab2){ref-type="table"}). The other social concerns related to PMTCT care investigated were not associated with disclosure to a relative. In addition, women in a current relationship (OR 0.35; 95% CI: 0.19--0.64) and women diagnosed with HIV \< 6 months compared to ≥6 months before enrolment (OR 0.20; 95% CI: 0.10--0.39) had significantly lower odds of having disclosed HIV status to a relative. Further adjustments, including ANC clinic of enrolment, provided similar results.

Discussion {#Sec14}
==========

In this cross-sectional study of pregnant women enrolled in PMTCT care in western Kenya, we observed that women who had not disclosed to a partner were more likely to have concerns about conflict, separation, and isolation or lack of support from family or friends. A high proportion had disclosed their HIV status to a current partner, and women \< 25 years of age were more likely to have disclosed their HIV status to a partner compared to women ≥25 years. The most prevalent social concern was involuntary HIV status disclosure.

Our study is, to our knowledge, the first quantitative study to assess social concerns related to participation in PMTCT Option B+ care and their association with HIV disclosure among pregnant women living with HIV. We found that concern about isolation or lack of support from family or friends appear to be barriers to HIV disclosure, which is in line with a recently published mixed-methods study from Tanzania where stigma in family and community was the most frequently cited reason for non-disclosure of HIV status among 24 women in PMTCT care \[[@CR23]\]. Our finding that concerns about conflict or separation appear to be a barrier for disclosure is also in line with one quantitative and five qualitative studies from SSA, suggesting that these concerns are important to address when developing strategies to promote HIV disclosure \[[@CR19]--[@CR23], [@CR25]\].

The high proportion of partner disclosure is in line with recently published data from Kenya \[[@CR39], [@CR41]\], including western Kenya \[[@CR42]\], suggesting that more women are disclosing their HIV status to their partners compared to earlier Kenyan studies \[[@CR11], [@CR36], [@CR43]--[@CR47]\]. In our study, younger women were more likely to have disclosed their HIV status to a partner compared to older women, indicating an increased openness and less stigma surrounding positive HIV status in younger couples in western Kenya, which could enable more male involvement in PMTCT care. While our results support those of a 2013 study of 250 pregnant women enrolled in PMTCT care in Tanzania \[[@CR33]\], a 2017 cross-sectional study from South Africa found that younger women enrolled in PMTCT were less likely to disclose their HIV status to a partner \[[@CR34]\]. In contrast to our study population, the majority of the women in the South African study were not married or cohabitating with a partner, and they used a different definition of being in a current relationship. A study published 2019 including 680 non-pregnant women living with HIV in Tanzania did not find age to be significantly associated with disclosure of HIV status \[[@CR38]\]. The study included older women (the majority were 35--49 years old), and the age intervals tested in the analysis were different (the youngest age interval was 17--34 years).

Our findings suggest that future interventional studies to further increase partner disclosure among women in PMTCT care, such as counselling in support groups \[[@CR48]\] or community interventions \[[@CR49]\], should consider focusing on women ≥25 years and women diagnosed with HIV during the past 6 months. Therefore, continued counselling at routine follow-up visits could support and empower women in this effort, helping reduce concerns about isolation or lack of support from family and friends as well as concerns about conflict and separation from a partner. Counselling could, for example, involve peer-support \[[@CR2], [@CR49]\] and discussing what to do in worst-case scenarios.

We observed that involuntary HIV status disclosure related to participation in HIV care was the most common social concern among pregnant women in our study. In line with our results, previous qualitative studies from SSA and Asia have reported that concern about unintentional HIV status disclosure has been identified as a barrier to visiting PMTCT care facilities \[[@CR13]--[@CR18]\]. Concern about involuntary HIV disclosure has been suggested to limit access to care by promoting fear and isolation among pregnant women in Kenya \[[@CR13]\]. Fear of breach of privacy and confidentiality have also been demonstrated to lead to loss to follow-up in PMTCT Option B+ care in Malawi \[[@CR14]\]. In order to promote retention in care, it is therefore crucial that policymakers and health care workers organizes PMTCT care so that the risk of involuntary HIV disclosure is minimized when pregnant women visit their health care facilities. We observed that most of the concerns related to PMTCT care were reported by a low proportion of women which is in line with a UNAIDS report showing that the proportion of women and men reporting discriminatory attitudes toward people living with HIV in Kenya decreased from 28% in 2009 to 12% in 2014 \[[@CR1]\]. The reduction in stigma is also supported by a 2017 mixed methods study from Uganda where a majority of women in PMTCT care felt that HIV-related stigma had reduced within their communities \[[@CR20]\].

Key strengths of this study include a recent data collection, the large sample size, high participation rate, and multicentre design including both rural and urban centres from a large area in western Kenya. The study had several limitations. The study had an observational, cross-sectional design and we can, therefore, only assess associations but not causality. In addition, we cannot rule out reverse causality. WelTel enrolment was restricted to women with access to a mobile phone (93% of women screened for participation in the WelTel trial), possibly reducing the population of women to which we can generalize. However, in recent years the mobile penetration level has increased in Kenya \[[@CR50]\]. It is also possible that women who declined to participate (5% of eligible women) did so because of social concerns or HIV related stigma, which would bias our prevalence estimates of social concerns related to participation in PMTCT care and HIV status disclosure. Finally, since our analysis was based on self-reports, risk of social desirability bias cannot be ruled out.

Conclusions {#Sec15}
===========

Compared to previous reports from Kenya, our estimated disclosure rate to a partner is higher, suggesting a possible improvement over time in disclosure. Younger pregnant women appear to be more likely to disclose, suggesting a possible decreased stigma and more openness about HIV among younger couples. Healthcare providers and future interventional studies seeking to increase partner disclosure should consider supporting women regarding their concerns about isolation, lack of support, separation, and conflict with a partner. PMTCT care should be organized to ensure women's privacy and confidentiality.
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**Additional file 1.** Questionaire used in structured interviews.
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IPV

:   Intimate partner violence
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